Clinical Trial Update: An Observational Study of CellCept (Mycophenolate Mofetil) in Renal Allograft Recipients

View source ↗

Summary

This is a completed observational study evaluating mycophenolate mofetil (CellCept) in kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Kidney Transplantation | Status: COMPLETED